Ana Preto

5.6k total citations · 1 hit paper
74 papers, 3.7k citations indexed

About

Ana Preto is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ana Preto has authored 74 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 29 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Ana Preto's work include Cancer-related Molecular Pathways (16 papers), Thyroid Cancer Diagnosis and Treatment (12 papers) and Cancer, Hypoxia, and Metabolism (10 papers). Ana Preto is often cited by papers focused on Cancer-related Molecular Pathways (16 papers), Thyroid Cancer Diagnosis and Treatment (12 papers) and Cancer, Hypoxia, and Metabolism (10 papers). Ana Preto collaborates with scholars based in Portugal, Spain and United Kingdom. Ana Preto's co-authors include Paula Soares, Manuel Sobrinho‐Simões, Valdemar Máximo, Raquel Seruca, Patrícia Castro, Jorge Lima, Andreia C. Gomes, Artur Cavaco‐Paulo, Eugénia Nogueira and Vítor Trovisco and has published in prestigious journals such as Oncogene, Biochemical Journal and Free Radical Biology and Medicine.

In The Last Decade

Ana Preto

72 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

2003 533 citations Paula Soares, Jorge Lima et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana Preto Portugal	34	1.8k	1.2k	1.1k	560	452	74	3.7k
Gayathri R. Devi United States	37	2.2k 1.2×	1.5k 1.3×	280 0.2×	791 1.4×	212 0.5×	96	4.3k
Valentina De Falco Italy	25	1.3k 0.7×	892 0.7×	732 0.6×	274 0.5×	205 0.5×	40	2.6k
Guojun Wu China	38	2.5k 1.4×	1.2k 1.0×	299 0.3×	761 1.4×	240 0.5×	102	4.1k
Kaoru Kiguchi United States	36	3.0k 1.6×	1.9k 1.6×	313 0.3×	832 1.5×	548 1.2×	77	5.3k
Nancy Krett United States	35	2.1k 1.2×	906 0.8×	284 0.3×	436 0.8×	250 0.6×	76	3.5k
Konstantin Christov United States	30	2.0k 1.1×	1.2k 1.0×	371 0.3×	521 0.9×	208 0.5×	100	3.7k
Vinod Gopalan Australia	37	2.2k 1.2×	860 0.7×	310 0.3×	1.4k 2.5×	290 0.6×	139	3.8k
Gennadi V. Glinsky United States	32	2.8k 1.5×	1.0k 0.9×	258 0.2×	825 1.5×	174 0.4×	75	4.1k
Yi Luo China	32	1.8k 1.0×	854 0.7×	247 0.2×	756 1.4×	169 0.4×	149	4.3k
Bal L. Lokeshwar United States	33	1.5k 0.8×	935 0.8×	170 0.2×	592 1.1×	343 0.8×	74	3.4k

Countries citing papers authored by Ana Preto

Since Specialization

Citations

This map shows the geographic impact of Ana Preto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Preto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Preto more than expected).

Fields of papers citing papers by Ana Preto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Preto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Preto. The network helps show where Ana Preto may publish in the future.

Co-authorship network of co-authors of Ana Preto

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Preto. A scholar is included among the top collaborators of Ana Preto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Preto. Ana Preto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Granja, Sara, Ana Preto, Odília Queirós, et al.. (2025). 3-Bromopyruvate boosts the effect of chemotherapy in acute myeloid leukemia by a pro-oxidant mechanism. Free Radical Biology and Medicine. 234. 192–202.

Alves, Sara, et al.. (2024). Enhancement of Acetate-Induced Apoptosis of Colorectal Cancer Cells by Cathepsin D Inhibition Depends on Oligomycin A-Sensitive Respiration. Biomolecules. 14(4). 473–473. 2 indexed citations

Rodrigues, Ana, et al.. (2023). Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy. International Journal of Molecular Sciences. 24(6). 5069–5069. 41 indexed citations

Côrte‐Real, Leonor, Nuno Mendes, Ana Sofia Ribeiro, et al.. (2022). Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model. Pharmaceutics. 14(7). 1388–1388. 13 indexed citations

Teixeira-Guedes, Catarina, et al.. (2022). Ruthenium(II)–Cyclopentadienyl-Derived Complexes as New Emerging Anti-Colorectal Cancer Drugs. Pharmaceutics. 14(6). 1293–1293. 15 indexed citations

Côrte‐Real, Leonor, Fernando Avecilla, Fernanda Marques, et al.. (2019). Ruthenium–Cyclopentadienyl Bipyridine–Biotin Based Compounds: Synthesis and Biological Effect. Inorganic Chemistry. 58(14). 9135–9149. 38 indexed citations

Francisco, Rita, Sophie Duban‐Deweer, Valérie Labas, et al.. (2019). Polymer “ruthenium-cyclopentadienyl” conjugates - New emerging anti-cancer drugs. European Journal of Medicinal Chemistry. 168. 373–384. 24 indexed citations

Côrte‐Real, Leonor, M. Paula Robalo, Fernando Avecilla, et al.. (2017). Novel ruthenium methylcyclopentadienyl complex bearing a bipyridine perfluorinated ligand shows strong activity towards colorectal cancer cells. European Journal of Medicinal Chemistry. 143. 503–514. 17 indexed citations

Amorim, Ricardo, Marta Viana‐Pereira, Céline Pinheiro, et al.. (2016). Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis. BMC Cancer. 16(1). 535–535. 49 indexed citations

10.

Nogueira, Eugénia, Andreia C. Gomes, Ana Preto, & Artur Cavaco‐Paulo. (2016). Update on Therapeutic Approaches for Rheumatoid Arthritis. Current Medicinal Chemistry. 23(21). 2190–2203. 30 indexed citations

11.

Azevedo‐Silva, João, Odília Queirós, Fátima Baltazar, et al.. (2016). The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside. Journal of Bioenergetics and Biomembranes. 48(4). 349–362. 61 indexed citations

12.

Nogueira, Eugénia, Ana Loureiro, Patrícia Nogueira, et al.. (2015). Assessment of liposome disruption to quantify drug delivery in vitro. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1858(2). 163–167. 11 indexed citations

13.

Soares, Paula, Jorge Lima, Ana Preto, et al.. (2011). Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas. Current Genomics. 12(8). 609–617. 68 indexed citations

14.

Xavier, Cristina P. R., Cristóvão F. Lima, Ana Preto, et al.. (2009). Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells. Cancer Letters. 281(2). 162–170. 145 indexed citations

15.

Preto, Ana, Cátia Moutinho, Sérgia Velho, et al.. (2007). A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 450(6). 619–626. 11 indexed citations

16.

Preto, Ana, Sim K. Singhrao, Michele F. Haughton, et al.. (2004). Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: implications for antitelomerase therapy. Oncogene. 23(23). 4136–4145. 15 indexed citations

17.

Preto, Ana, José Cameselle‐Teijeiro, Paula Soares, et al.. (2004). Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests. Modern Pathology. 17(7). 819–826. 47 indexed citations

18.

Reis‐Filho, Jorge S., Ana Preto, Paula Soares, et al.. (2003). p63 Expression in Solid Cell Nests of the Thyroid: Further Evidence for a Stem Cell Origin. Modern Pathology. 16(1). 43–48. 79 indexed citations

19.

Schmitt, Fernando, et al.. (2003). Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 443(2). 122–132. 174 indexed citations

20.

Zemzoumi, Khalid, E. Guilvard, Denis Séréno, et al.. (1999). Cloning of a Leishmania major gene encoding for an antigen with extensive homology to ribosomal protein S3a. Gene. 240(1). 57–65. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact